Literature DB >> 18987816

Identification and quantification of differentially methylated loci by the pyrosequencing technology.

Emelyne Dejeux1, Hafida El abdalaoui, Ivo Glynne Gut, Jörg Tost.   

Abstract

Most available protocols for gene-specific DNA methylation analysis are either labor intensive, not quantitative, or limited to the measurement of the methylation status of only one or very few CpG positions. Pyrosequencing is a real-time sequencing technology that overcomes these limitations. After bisulfite modification of genomic DNA, a region of interest is amplified by polymerase chain reaction (PCR) with one of the two primers being biotinylated. The PCR-generated template is rendered single stranded and a pyrosequencing primer is annealed to analyze quantitatively CpGs within 120 bases. Advantages of the pyrosequencing technology are the ease of its implementation, the high quality and the quantitative nature of the results, and its ability to identify differentially methylated positions in close proximity. A minimum amount of 10 ng of bisulfite-treated DNA is necessary to obtain high reproducibility and avoid random amplification. The required DNA amount can be provided by an individual sample or a pool of samples to rapidly investigate the presence of variable DNA methylation patterns. The use of pools and serial pyrosequencing, that is, the successive use of several pyrosequencing primers on the same DNA template, significantly reduces cost, labor, and analysis time as well as saving precious DNA samples for the analysis of gene-specific DNA methylation patterns.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18987816     DOI: 10.1007/978-1-59745-522-0_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  24 in total

1.  Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.

Authors:  Hsiang-Yu Lin; Yi-Chiu Kuo; Yu-I Weng; I-Lu Lai; Tim H-M Huang; Shuan-Pei Lin; Dau-Ming Niu; Ching-Shih Chen
Journal:  Prostate       Date:  2012-04-26       Impact factor: 4.104

2.  Comprehensive mapping of the methylation landscape of 16 CpG-dense regions in oral and pharyngeal squamous cell carcinoma.

Authors:  Scott M Langevin; Damaris Kuhnell; Liang Niu; Jacek Biesiada; Yuet-Kin Leung; Ranjan Deka; Aimin Chen; Mario Medvedovic; Karl T Kelsey; Susan Kasper; Xiang Zhang
Journal:  Epigenomics       Date:  2019-06-19       Impact factor: 4.778

Review 3.  Deciphering the epigenetic code: an overview of DNA methylation analysis methods.

Authors:  Muhammad Umer; Zdenko Herceg
Journal:  Antioxid Redox Signal       Date:  2013-01-22       Impact factor: 8.401

4.  Epigenetic regulation of the glucocorticoid receptor promoter 1(7) in adult rats.

Authors:  Simone R Witzmann; Jonathan D Turner; Sophie B Mériaux; Onno C Meijer; Claude P Muller
Journal:  Epigenetics       Date:  2012-09-28       Impact factor: 4.528

5.  Promoter methylation of the SALL2 tumor suppressor gene in ovarian cancers.

Authors:  Chang K Sung; Dawei Li; Erik Andrews; Ronny Drapkin; Thomas Benjamin
Journal:  Mol Oncol       Date:  2012-12-12       Impact factor: 6.603

6.  Cross-tissue comparisons of leptin and adiponectin: DNA methylation profiles.

Authors:  Andrée-Anne Houde; Cécilia Légaré; Frédéric-Simon Hould; Stéfane Lebel; Picard Marceau; André Tchernof; Marie-Claude Vohl; Marie-France Hivert; Luigi Bouchard
Journal:  Adipocyte       Date:  2014-02-25       Impact factor: 4.534

7.  Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy.

Authors:  Ilsiya Ibragimova; Paul Cairns
Journal:  Methods Mol Biol       Date:  2011

Review 8.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

Review 9.  16S rRNA Methyltransferases as Novel Drug Targets Against Tuberculosis.

Authors:  M R Salaikumaran; Veena P Badiger; V L S Prasad Burra
Journal:  Protein J       Date:  2022-02-03       Impact factor: 2.371

10.  Leukocyte DNA as surrogate for the evaluation of imprinted Loci methylation in mammary tissue DNA.

Authors:  Ludovic Barault; Rachel E Ellsworth; Holly R Harris; Allyson L Valente; Craig D Shriver; Karin B Michels
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.